{"id":365,"date":"2026-08-27T09:41:04","date_gmt":"2026-08-27T09:41:04","guid":{"rendered":"https:\/\/nhdbio.com\/products\/survodutide\/"},"modified":"2026-08-28T07:01:53","modified_gmt":"2026-08-28T07:01:53","slug":"survodutide","status":"publish","type":"product_family","link":"https:\/\/nhdbio.com\/de\/products\/survodutide\/","title":{"rendered":"Survodutide"},"content":{"rendered":"<p>Survodutide ist ein in der Entwicklung befindlicher Peptidagonist zur Aktivierung von Glucagon- und GLP-1-Rezeptoren. In der Phase-3-Studie SYNCHRONIZE-1 aus dem Jahr 2026 kam es bei 725 Erwachsenen mit Adipositas ohne Diabetes in Woche 76 zu einer st\u00e4rkeren durchschnittlichen K\u00f6rpergewichtsreduktion unter Survodutid als unter Placebo, w\u00e4hrend gastrointestinale Nebenwirkungen h\u00e4ufig auftraten. Die Studienergebnisse geh\u00f6ren zur untersuchten Intervention und validieren dieses Katalogforschungsmaterial nicht.<\/p>","protected":false},"excerpt":{"rendered":"<p>Survodutide ist ein in der Entwicklung befindlicher Peptidagonist zur Aktivierung von Glucagon- und GLP-1-Rezeptoren. In der Phase-3-Studie SYNCHRONIZE-1 aus dem Jahr 2026 kam es bei 725 Erwachsenen mit Adipositas ohne Diabetes in Woche 76 zu einer st\u00e4rkeren durchschnittlichen K\u00f6rpergewichtsreduktion unter Survodutid als unter Placebo, w\u00e4hrend gastrointestinale Nebenwirkungen h\u00e4ufig auftraten. Die Studienergebnisse geh\u00f6ren zur untersuchten Intervention und validieren dieses Katalogforschungsmaterial nicht.<\/p>","protected":false},"author":0,"featured_media":607,"template":"","class_list":["post-365","product_family","type-product_family","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Survodutide Research Product | Evidence &amp; Specifications<\/title>\n<meta name=\"description\" content=\"Survodutide is an investigational peptide agonist designed to activate glucagon and GLP-1 receptors. In the 2026 SYNCHRONIZE-1 phase 3 trial, 725 adults wi\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/de\/products\/survodutide\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Survodutide\" \/>\n<meta property=\"og:description\" content=\"Survodutide is an investigational peptide agonist designed to activate glucagon and GLP-1 receptors. In the 2026 SYNCHRONIZE-1 phase 3 trial, 725 adults wi\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/de\/products\/survodutide\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-28T07:01:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/product-family-mockups\/survodutide-product-family-mockup-20260828.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/products\\\/survodutide\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/products\\\/survodutide\\\/\",\"name\":\"Survodutide Research Product | Evidence & Specifications\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/products\\\/survodutide\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/products\\\/survodutide\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/product-family-mockups\\\/survodutide-product-family-mockup-20260828.webp\",\"datePublished\":\"2026-08-27T09:41:04+00:00\",\"dateModified\":\"2026-08-28T07:01:53+00:00\",\"description\":\"Survodutide is an investigational peptide agonist designed to activate glucagon and GLP-1 receptors. In the 2026 SYNCHRONIZE-1 phase 3 trial, 725 adults wi\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/products\\\/survodutide\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/products\\\/survodutide\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/products\\\/survodutide\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/product-family-mockups\\\/survodutide-product-family-mockup-20260828.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/product-family-mockups\\\/survodutide-product-family-mockup-20260828.webp\",\"width\":1536,\"height\":1024,\"caption\":\"AI-generated packaging mockup for catalog navigation. It is not a photograph of an actual supplied lot; container, label and presentation may vary.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/products\\\/survodutide\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u4ea7\u54c1\u5bb6\u65cf\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/products\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Survodutide\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Survodutide Forschungsprodukt | Beweise und Spezifikationen","description":"Survodutide ist ein in der Entwicklung befindlicher Peptidagonist, der zur Aktivierung von Glucagon- und GLP-1-Rezeptoren entwickelt wurde. In der 2026 SYNCHRONIZE-1-Phasen-3-Studie untersuchten 725 Erwachsene mit\u2026","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/de\/products\/survodutide\/","og_locale":"de_DE","og_type":"article","og_title":"Survodutide","og_description":"Survodutide is an investigational peptide agonist designed to activate glucagon and GLP-1 receptors. In the 2026 SYNCHRONIZE-1 phase 3 trial, 725 adults wi\u2026","og_url":"https:\/\/nhdbio.com\/de\/products\/survodutide\/","og_site_name":"NHD","article_modified_time":"2026-08-28T07:01:53+00:00","og_image":[{"width":1536,"height":1024,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/product-family-mockups\/survodutide-product-family-mockup-20260828.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/products\/survodutide\/","url":"https:\/\/nhdbio.com\/products\/survodutide\/","name":"Survodutide Forschungsprodukt | Beweise und Spezifikationen","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/products\/survodutide\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/products\/survodutide\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/product-family-mockups\/survodutide-product-family-mockup-20260828.webp","datePublished":"2026-08-27T09:41:04+00:00","dateModified":"2026-08-28T07:01:53+00:00","description":"Survodutide ist ein in der Entwicklung befindlicher Peptidagonist, der zur Aktivierung von Glucagon- und GLP-1-Rezeptoren entwickelt wurde. In der 2026 SYNCHRONIZE-1-Phasen-3-Studie untersuchten 725 Erwachsene mit\u2026","breadcrumb":{"@id":"https:\/\/nhdbio.com\/products\/survodutide\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/products\/survodutide\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/nhdbio.com\/products\/survodutide\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/product-family-mockups\/survodutide-product-family-mockup-20260828.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/product-family-mockups\/survodutide-product-family-mockup-20260828.webp","width":1536,"height":1024,"caption":"AI-generated packaging mockup for catalog navigation. It is not a photograph of an actual supplied lot; container, label and presentation may vary."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/products\/survodutide\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"\u4ea7\u54c1\u5bb6\u65cf","item":"https:\/\/nhdbio.com\/products\/"},{"@type":"ListItem","position":3,"name":"Survodutide"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Peptidrohstoffe und individuelle Peptidsynthese","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/product_family\/365","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/product_family"}],"about":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/types\/product_family"}],"version-history":[{"count":2,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/product_family\/365\/revisions"}],"predecessor-version":[{"id":482,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/product_family\/365\/revisions\/482"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/media\/607"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/media?parent=365"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}